OSOM C. Difficile Toxin A/B Test Kit Recalled for False Negative Risk
Sekisui Diagnostics is recalling specific lots of the OSOM C. Difficile Toxin A/B Test Kit due to the potential for false negative results.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall involves a medical diagnostic device with a potential for false negative results, which poses a risk of harm by potentially delaying correct diagnosis and treatment, but no specific injuries or illnesses have been reported in the source text.
Plain-English summary
Sekisui Diagnostics LLC has issued a Product Correction for certain lot numbers of the OSOM C. Difficile Toxin A/B Test Kit. The recall involves 391 kits distributed worldwide, including the United States, UK, Saudi Arabia, Dubai, Kuwait, Poland, Spain, India, and Romania. The affected product is a qualitative in vitro diagnostic assay used to detect Clostridium difficile toxins A and/or B in human stool samples to aid in the diagnosis of C. difficile associated disease.
The recall was initiated because it has been determined that there is a potential for false negative results. The specific part number and lot number combinations affected are: PN:173E, LN:121272; PN:173, LN:121273; PN:173, LN:121273A; PN:173E, LN:131155; and PN:173, LN:131156.
Healthcare facilities and distributors should check their inventory for these specific lot numbers. If the product is found, it should be removed from use and returned to the manufacturer or authorized distributor in accordance with the recall instructions.
The recalled product
- Product
- Product Name: OSOM C. Difficile Toxin A/B Test Catalog Numbers: 173 (for United States) and 173 E (for Europe). The Test is a qualitative assay (in vitro diagnostic) that employs immunochromatographic, dipstick technology. If C. difficile toxin A or toxin B is present, a blu
- Manufacturer
- Sekisui Diagnostics LLC
- Affected units
- 391
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- The following are part numbers and lot number combinations. PN:173E
- LN:121272. PN:173
- LN:121273. PN:173
- LN:121273A. PN:173E
- LN:131155. PN:173
- LN:131156.
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Sekisui Diagnostics LLC
See all →- ModerateSekisui Spectrolyse PAI-1 Assay Recalled for Lower Absorbance Values
FDA (Devices) · 2012-12-12
- ModerateSekisui Spectrolyse PAI-1 Assay Recalled for Lower Absorbance Values
FDA (Devices) · 2012-09-26
- ModerateSekisui Recalls 1,600 Acetaminophen Assay Kits Due to Reagent Discoloration
FDA (Devices) · 2012-07-04
Same hazard · false negative result
See all →- HighBioFire Respiratory Panel 2.1 Recalled for Increased False Negative Results
FDA (Devices) · 2026-08-19
- HighVITEK 2 AST-N447 Test Kit Potentially Returns False Resistant Results
FDA (Devices) · 2026-07-15
- HighLuminex VERIGENE Gram Negative Blood Culture Test Recalled
FDA (Devices) · 2025-06-11
- HighVERIGENE Clostridium difficile Nucleic Acid Test May Give False-Negative Results
FDA (Devices) · 2023-07-05
- HighMedical device test system recalled for decreased reactivity and false-negative results
FDA (Devices) · 2022-12-07